Login / Signup
Ankit Shah
ORCID
Publication Activity (10 Years)
Years Active: 2021-2021
Publications (10 Years): 1
Top Topics
Drug Administration
Diffuse Large B Cell Lymphoma
Double Blind
Tyrosine Kinase
Top Venues
OncoTargets and therapy
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Ankit Shah
,
Jacqueline Claudia Barrientos
Oral PI3K-δ,γ Inhibitor for the Management of People with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: A Narrative Review on Duvelisib.
OncoTargets and therapy
14 (2021)